This study aims to improve how oral mucosal disorders-such as oral lichen planus, recurrent aphthous stomatitis, burning mouth syndrome, herpes viral infection and oral candidiasis-are treated in dental settings. A pharmacist will work with dentists to review prescriptions, provide feedback, counsel patients, and monitor medication safety. Dental clinics will be assigned to either the pharmacist-led model or usual care. The study will evaluate whether this approach improves prescribing quality, patient adherence, symptom control, and safety. The findings may help establish a more standardized, effective way to manage these common oral conditions in routine dental practice.
Adults aged 18 years and above
Diagnosed with an oral mucosal disorder (oral lichen planus, recurrent aphthous stomatitis, burning mouth syndrome, Herpes viral infection or oral candidiasis)
Attending participating dental clinic sessions during the study period
Prescribed pharmacological treatment for the oral mucosal condition
Patients without a confirmed diagnosis of an oral mucosal disorder
Patients requiring immediate emergency care or hospitalization
Patients currently enrolled in another interventional clinical trial
Known hypersensitivity to commonly prescribed medications used in the study
University of Fujairah
Lead sponsor
Sri Balaji Vidyapeeth University
Collaborator